MiNK Therapeutics Stock (NASDAQ:INKT), Quotes and News Summary

Q: What sector and industry does MiNK Therapeutics (INKT) operate in?

MiNK Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

MiNK Therapeutics Stock (NASDAQ: INKT) stock price, news, charts, stock research, profile.

Open	$0.990
Close	-
Volume / Avg.	19.680K / 96.271K
Day Range	0.932 - 0.990
52 Wk Range	0.750 - 3.340
Market Cap	$33.655M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	51
Short Interest	0.77%
Days to Cover	1.05

Recent News

Why Byrna Technologies Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of Byrna Technologies Inc. (NASDAQ: BYRN) rose sharply during Friday’s session after the company reported better-than-expected first-quarter revenue, and announced a CFO transition.

Avi Kapoor

Sacks Parente Golf And 3 Other Stocks Under $2 Insiders Are Buying

The Dow Jones closed higher by more than 300 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

Cadrenal Therapeutics And 3 Other Stocks Under $3 Insiders Are Buying

The Dow Jones closed higher by around 290 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About MiNK Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy MiNK Therapeutics (INKT) stock?

You can purchase shares of MiNK Therapeutics (NASDAQ: INKT) through any online brokerage.

View our list of the best stock brokerages.

Who are MiNK Therapeutics's (INKT) competitors?

Other companies in MiNK Therapeutics’s space includes: NKGen Biotech (NASDAQ:NKGN), Fortress Biotech (NASDAQ:FBIO), Estrella Immunopharma (NASDAQ:ESLA), Acurx Pharmaceuticals (NASDAQ:ACXP) and OncoCyte (NASDAQ:OCX).

What is the target price for MiNK Therapeutics (INKT) stock?

The latest price target for MiNK Therapeutics (NASDAQ: INKT) was reported by HC Wainwright & Co. on Thursday, March 21, 2024. The analyst firm set a price target for 9.00 expecting INKT to rise to within 12 months (a possible 826.31% upside). 3 analyst firms have reported ratings in the last year.

Current Stock Price for MiNK Therapeutics (INKT)?

The stock price for MiNK Therapeutics (NASDAQ: INKT) is $0.971599 last updated Today at April 30, 2024 at 11:07 AM EDT.

Does MiNK Therapeutics (INKT) pay a dividend?

There are no upcoming dividends for MiNK Therapeutics.

When is MiNK Therapeutics (NASDAQ:INKT) reporting earnings?

MiNK Therapeutics’s Q1 earnings are confirmed for Tuesday, May 14, 2024.

Is MiNK Therapeutics (INKT) going to split?

There is no upcoming split for MiNK Therapeutics.

What sector and industry does MiNK Therapeutics (INKT) operate in?

MiNK Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-